Stock 6833 SINCO PHARMACEUTICALS HOLDINGS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Sinco Pharmaceuticals Holdings Limited

Equities

6833

KYG8154Y1052

Pharmaceuticals

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:17 2024-05-07 am EDT 		5-day change 1st Jan Change
0.24 HKD 0.00% Intraday chart for Sinco Pharmaceuticals Holdings Limited -4.00% 0.00%
Mar. 26 Sinco Pharmaceuticals Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Mar. 26 Sinco Pharmaceuticals Holdings Limited Resignation of Li Kin Wai as Joint Company Secretary and Appointment of Peng Yunlu as Executive Director CI

Business Summary

Sinco Pharmaceuticals Holdings Limited operates as one provider of marketing, promotion and channel management (MPCM) services in the People's Republic of China (PRC) pharmaceutical industry. It provides its integrated MPCM services to small- and medium-sized overseas pharmaceutical manufacturers that do not possess independent marketing and promotion capabilities in China. Its major product is human albumin solution, a human albumin product manufactured by Octapharma, which is used to remedy hypovolemia and hypovolemic shock, abnormally high intracranial pressure, edema and ascites, and to prevent and cure hypoalbuminemia and neonatal hyper-bilirubinemia. In addition, its products include axetine, medocef, esafosfina, tad and taurolite.

Number of employees: 278

Sales per Business

HKD in Million2022Weight2023Weight Delta
Imported Pharmaceutical Products
99.0 %
2,627 99.5 % 2,778 99.0 % +5.74%
Medical Beauty Services
1.0 %
14 0.5 % 29 1.0 % +102.06%

Sales per region

HKD in Million2022Weight2023Weight Delta
China
100.0 %
2,641 100.0 % 2,807 100.0 % +6.26%

Managers

Managers TitleAgeSince
Min Jin CEO
 Chief Executive Officer 47 20-11-05
Xiang Bin Huang FOU
 Founder 59 11-03-31
Yi Fan Li DFI
 Director of Finance/CFO 45 15-01-31
Yun Lu Peng SEC
 Corporate Secretary 33 19-10-24
Kin Wai Liu
42 -

Members of the board

Members of the board TitleAgeSince
Ying Kit Lau BRD
 Director/Board Member 50 18-11-07
Wen Fang Liu BRD
 Director/Board Member 87 16-01-31
Xiang Bin Huang FOU
 Founder 59 11-03-31
Qing Wang BRD
 Director/Board Member 60 16-01-31
Zhizhong Bai BRD
 Director/Board Member 67 20-08-31
Shi Feng Lei BRD
 Director/Board Member 57 23-03-28

Shareholders

NameEquities%Valuation
Xiang Bin Huang
51.65 %
1,050,000,000 51.65 % 35 M $
Min Jin
0.6729 %
13,680,000 0.6729 % 454 450 $
HAC VermögensManagement AG
0.0132 %
268,000 0.0132 % 8 903 $

Company contact information

Sinco Pharmaceuticals Holdings Ltd.

E5-1805, Global Centre No.1700, North Section

610041, Chengdu

+

http://www.sinco-pharm.com
address Sinco Pharmaceuticals Holdings Limited(6833)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Pharmaceuticals Wholesale

Sales per Business

Sector Pharmaceuticals Wholesale

1st Jan change Capi.
SINCO PHARMACEUTICALS HOLDINGS LIMITED Stock Sinco Pharmaceuticals Holdings Limited
0.00% 62.42M
MCKESSON CORPORATION Stock McKesson Corporation
+16.61% 70.09B
CARDINAL HEALTH, INC. Stock Cardinal Health, Inc.
-1.42% 24.01B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD Stock Shanghai Pharmaceuticals Holding Co., Ltd
+8.01% 8.32B
HUADONG MEDICINE CO., LTD Stock Huadong Medicine Co., Ltd
-18.28% 8.23B
SINOPHARM GROUP CO. LTD. Stock Sinopharm Group Co. Ltd.
0.00% 8.08B
H. LUNDBECK A/S Stock H. Lundbeck A/S
+4.40% 4.68B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD Stock Jointown Pharmaceutical Group Co., Ltd
+16.55% 4.41B
EBOS GROUP LIMITED Stock EBOS Group Limited
-0.70% 4.12B
GALENICA AG Stock Galenica AG
-2.20% 3.88B
Pharmaceuticals Wholesale
  1. Stock Market
  2. Equities
  3. 6833 Stock
  4. Company Sinco Pharmaceuticals Holdings Limited
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW